Feb 27, 2017
|
Ardelyx Announces Presentation at Cowen and Company 37th Annual Healthcare Conference
|
Feb 17, 2017
|
Ardelyx Reports Clinical Progress and Fourth Quarter and Full Year 2016 Financial Results
|
Feb 15, 2017
|
Ardelyx Announces Successful Phase 3 Trial of Tenapanor for Hyperphosphatemia in Patients with End-Stage Renal Disease
|
Jan 3, 2017
|
Ardelyx Announces Initiation of Two Clinical Trials for RDX7675 for Treatment of Hyperkalemia
|
Jan 3, 2017
|
Ardelyx Announces Presentation at J.P. Morgan 35th Annual Healthcare Conference
|
Nov 7, 2016
|
Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress
|
Oct 31, 2016
|
Ardelyx to Announce Third Quarter 2016 Financial Results on November 7, 2016
|
Oct 24, 2016
|
Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
|
Oct 19, 2016
|
Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting
|
Sep 22, 2016
|
Ardelyx to Present at Ladenburg Thalmann 2016 Healthcare Conference
|